Summary. The synergic relationship between Escherichia coli and Bacteroides fragilis was examined in a model of intra-abdominal abscess formation. The addition of B. fragilis to E. coli in the fibrin clot inoculum increased abscess weight and residual numbers of E. coli in the abscess at 7 days. In a reciprocal fashion, E. coli was capable of enhancing B. fragilis persistence in abscesses. Neither heat-killed E. coli nor heatkilled B. fragilis was able to mimic the synergic effect of its live counterpart. Furthermore, B. fragilis culture filtrate was unable to reproduce the ability of live B. fragilis to act synergically with E. coli. For B. fragilis to act synergically with E. coli, it had to be inoculated locally with E. coli in the peritoneal cavity, indicating that an effect on systemic resistance by B. fragilis was an unlikely mechanism for the production of bacterial synergy. These studies suggest that the synergic relationship between bacteria in polymicrobial infections is a complex one, resulting from intimate interactions between bacteria and the host in the local milieu of the infection.
Introduction
The microbial flora of peritonitis resulting from perforation of the lower gastrointestinal tract consists of a mixture of aerobic and anaerobic bacteria (Lorber and Swenson, 1975) . Several studies have demonstrated the importance of directing antimicrobial therapy against both components of the polymicrobial flora in the management of intra-abdominal infection (Berne et al., 1982; Gorbach, 1984) . However, much remains to be learned about the interactions between aerobic and anaerobic bacteria in determining the detailed pathogenesis of these infections.
The purpose of these studies was to examine potential mechanisms of pathogenic synergy between Escherichia coli and Bacteroides fragilis in uiuo. Most studies of bacterial synergy have employed subcutaneous infection models (Kelly, 1978 ; Brook et al., 1984 ; MacLaren et al., 1984 ; Verweijvan Vught et al., 1985) . Host defence mechanisms in these infections differ markedly from those active in the peritoneal cavity (Delong and Simmons, 1982; Dunn et al., 1987) . As a result, conclusions derived from these studies may not pertain directly to the setting of intra-abdominal infection. Onderdonk et al. (1976) clearly established the synergic relationship between E. coli and B. fragilis in an intra-abdominal infection model. However, subsequent studies have focused on the mechanisms by which B. fragilis capsular polysaccharide induces abscess formation (Onderdonk et al., 1977; Shapiro et al., 1982 Shapiro et al., , 1986 . In the present studies, the mechanisms of E. coli-B. fragilis interactions were examined in an intra-abdominal model of mixed infection to closely mimic the clinical setting. Using this model, we have previously shown bacterial synergy between E. coli and B. fragilis with respect to lethality and abscess formation (Rotstein et al., 1987; Rotstein and Kao, 1988) . The initial inoculum of E. coli in the bacterial mixture was the prime determinant of whether synergic lethality or abscess formation occurred. With a high E. coli inoculum (> lo8 cfu), the addition of B. fragilis to E. coli resulted in an enhanced mortality rate compared to that resulting from inoculation of either organism alone. At a lower E. coli inoculum (< lo8 cfu), the combination of E. coli plus B. fragilis rarely caused death but resulted in synergic abscess formation. In this report, the reciprocal nature of the synergic relationship between E. coli and B. fragilis is 
Materials and methods

Bacterial strains and growth conditions
A serum-resistant strain of E. coli, 00, isolated from a patient at the University of Minnesota Hospitals and a strain of B. fragilis, VPI 9032, obtained from Dr T. D. Wilkins, Virginia Polytechnic Institute and State University (VPI), Blacksburg, VA, were used in these studies. Techniques of storage, growth conditions, medium ingredients and methods of enumeration have been previously described (Namavar et al., 1983; Rotstein et al., 1987) .
For inoculation into the fibrin clot, the B. fragilis culture was pelleted by centrifugation at 1600g for 10 min, and resuspended in pre-reduced Hanks's Balanced Salts Solution (HBSS, Gibco, Grand Island, NY) supplemented with cysteine hydrochloride (Sigma Chemical Company, St Louis, MO) 0.5 mg/L.
Incorporation of bacteria intoJibrin clots
Human fibrinogen (Sigma) 2 g/L was sterilised with ultraviolet light for 10 min. For preparation of infected clots, 1.4 ml of fibrinogen was added to a 75 x 12 mm polystyrene tube in an anaerobic chamber. Either E. coli in 0-2 ml of saline, B. fragilis in 0.2 ml of pre-reduced HBSS, or both, were added to the fibrinogen solution before clotting with thrombin (Parke-Davis, Morris Plains, NJ) 6 U in 0.2 ml. In monomicrobial clots, the appropriate control vehicle was used to replace the synergic bacterial partner. In studies examining the ability of B. fragilis culture supernates to act synergically with E. coli, 0.2 ml of filter-sterilised 24-h cultures of B. fragilis or sterile culture broth were substituted for the inoculum of B. fragilis. For some studies, bacteria (either E. coli or B. fragilis VPI 9032) were heat-killed by boiling for 15 min. Killing was confirmed by aerobic and anaerobic culture. Bacterial numbers were adjusted by counting in a Petroff-Hauser chamber followed by appropriate dilution.
Fibrin-clot peritonitis model
Male Wistar rats, weighing 200-250 g, were inoculated intraperitoneally (i.p.) with infected fibrin clots as previously described (Rotstein et al., 1985) . Briefly, a single clot was inserted i.p. into a rat under halothanenitrous oxide anaesthesia via a midline incision. The incision was closed with clips. Total anaesthesia time was 4-6 min. Animals were weighed daily and deaths were recorded.
Quantitation of viable bacteria in abscesses
On day 7, rats were killed by C 0 2 asphyxiation. At laparotomy, the peritoneal cavity was inspected for the presence of abscesses. Abscess formation in this model was defined as the presence of a single walled-off collection of purulent material. Swabs of the peritoneal cavity were always sterile. The abscess was excised aseptically, weighed, and carefully minced into a tube containing prereduced HBSS and sterile glass beads held under a VPI anaerobe apparatus (Holdeman et al., 1977; Wells et al., 1985) . The tube was stoppered, vortex mixed, and transferred to an anaerobic chamber. The tube contents were then serially diluted in prereduced HBSS and surface plated in duplicate on supplemented Brain Heart Infusion Agar (BHIA; Difco Laboratories, Detroit, MI) and nutrient agar (NA). The supplemented BHIA plates were incubated anaerobically at 35°C for 48 h and the NA plates were incubated aerobically at 37°C for 24 h. The numbers of viable bacteria were quantitated and converted to log,, values. The limit of detection of bacteria in abscesses was 2.7 log,, cfu/ml.
Statistical analysis
Data on abscess weights and viable bacterial numbers in abscesses were analysed by a one-way analysis of variance and differences between groups were tested by Student's t test.
Results
Mortality
The mortality rate throughout these studies was low and varied according to the bacterial inoculum. Monomicrobial E. coli inocula (2 x lo6 or 2 x lo7 cfu/clot) resulted in no deaths amongst 76 animals and B. fragilis 2 x lo9 cfu/clot did so on only one occasion ( -5%). The combination of E. coli 2 x lo6 or 2 x lo7 cfu/clot plus B. fragilis 2 x lo9 cfu/clot caused death in 4 out of 31 animals (13%). The simultaneous inoculation of E. coli 2 x lo7 cfu i.p. within a fibrin clot with B . fragilis 2 x lo7 cfu administered either free i.p., subcutaneously, intravenously or in a separate i.p. fibrin clot resulted in a mortality rate of 19% (1 1 out of 58). Lower inocula of B. fragilis enmeshed with E. coli 2 x lo7 cfu/clot did not cause death in 24 animals. Finally, E. coli 2 x lo7 cfu mixed with either dead B. fragilis, sterile culture medium or B. fragilis culture filtrate caused a 12% mortality rate (6 out of 49). Animals who died before the 7-day evaluation were not assessed for abscess formation and were thus excluded from further analysis.
Efect of mixed infection on abscess formation and bacterial numbers
An inoculum of E. coli 2 x lo7 cfu/clot produced abscesses in 80% (41 out of 52) of animals. These abscesses were generally small and contained low numbers of E. coli (3.2 SD 0.5 log,, cfu/ml). B. fragilis-infected clots, at the highest inoculum tested (2 x lo9 cfu/clot), frequently caused abscesses (94%, 17 out of 18) and these contained large numbers of bacteria (7.8 SD 0.6 log,, cfulml) (table I) . At all the lower inocula tested, B. fragilis did not produce true abscesses. Any abscesses seen were small (0-03-0-1 g) and consisted of a residual fibrin nidus which was frequently sterile, rather than the welldefined abscesses with a central purulent area and a collagenous capsule produced by high E. coli or B. fragilis inocula.
The addition of high doses of B. fragilis (2 x lo9 cfu) to E. coli (2 x lo7 cfu) in the fibrin clot inoculum resulted in significantly larger abscesses than were produced with either E. coli or B. fragilis alone (p < 0.05). The abscesses were quantitatively more purulent than monomicrobial abscesses and had higher numbers of E. coli (7.4 SD 0.3 log,, cfu/ml us 3.2 SD 0.5 log,, cfu/ml; p<O.OOOl). B. fragilis numbers were increased in mixed abscesses but differences were not statistically significant.
At intermediate doses of B. fragilis a reciprocal synergic relationship between E. coli and B. fragilis was demonstrated. There were significantly greater numbers of viable E. coli in abscesses initiated with a mixture of E. coli and B. fragilis (2 x lo7 cfu/clot or 2 x lo5 cfu/clot) than in abscesses initiated by E. coli alone (5.4 SD 0.3 log,, cfu/ml and 5.5 SD 0.2 log,, cfu/ml respectively for mixed abscesses us 3.2 SD 0.5 log,, cfu/ml for E. coli alone; p<0.005). Furthermore, whereas B . fragilis inoculated alone at either of these doses resulted in small, frequently sterile abscesses, the presence of E. coli in the initial inoculum resulted in abscesses containing large numbers of B. fragilis.
The combination of E. coli plus B. fragilis at the lower inocula (2 x lo3 cfu/clot and 2 x lo2 cfu/clot) produced abscesses of similar size and with similar E. coli viable counts as those caused by E. coli alone. The ability of E. coli to increase survival of B. fragilis inoculated at 2 x lo3 cfu/clot persisted, but the effect was less evident than at higher B. fragilis i noc ula.
Efect of bacterial Viability on E. coli-B. fragilis synergy
To determine the role of bacterial viability on the production of E. coli-B. fragilis synergy, heatkilled B. fragilis were added to live E. coli in the fibrin clot inoculum (table 11) . Dead B. fragilis at inocula of 2 x lo9 particles or 2 x 10" particles did not increase the weight of, or E. coli viable counts in, abscesses compared to E. coli alone, although mixed inocula containing 2 x 10" dead B. fragilis did result in significantly higher E. coli counts than those produced with 2 x lo9 dead B. fragilis plus E. coli (p < 0.01). Inoculation of dead B. fragilis alone did not result in abscess formation (6 animals were used for each dose). The data from two animals (one given E. coli plus 2 x lo9 dead B. fragilis and one given E. coli plus 2 x 10" dead B. fragilis) were excluded from analysis because quantitative abscess counts revealed the presence of live B. fragilis. 0.10 (0.02) . . . . . . Interestingly, these abscesses were large and contained high numbers of both E. coli and B. fragilis. In a reciprocal fashion, synergy was not demonstrated when 2 x lo7 heat-killed E. coli and 2 x lo7 cfu of live B. fragilis were inoculated together i.p. within a fibrin clot (data not shown).
Efect of B. fragilis cultureJiltrates on E. coli abscess formation
Filter-sterilised, 24-h culture filtrates of B.fragi1i.s were added to E. coli fibrin clot inocula to determine whether a soluble by-product of B. fragilis was responsible for E. coli-B. fragilis synergy. As shown in table 111, B. fragilis filtrates did not increase abscess size or final E. coli numbers in abscesses when compared to E. coli alone or to E. coli combined with sterile culture medium.
Efect of the location of B. fragilis on its ability to act synergically with E. coli
To determine whether the mechanism of E. coli-B. fragilis synergy required direct interaction between E. coli and B. fragilis, B. fragilis inocula were administrated by various routes simultaneously with the i.p. insertion of a fibrin clot containing E. coli 2 x 10'. Table IV shows that synergy occurred only when E. coli and B. fragilis were both inoculated i.p. whether in the same clot, in separate clots or when B. fragilis was given free i.p. in the presence of an E. coli clot, although in the latter case figures did not reach statistical significance. In the 10 rats given B. fragilis and E. coli clots simultaneously i.p., there was always a single abscess present at 7 days and in nine of these animals the abscess contents contained both E. coli and B. fragilis in high numbers. In one animal, the abscess contained only E. coli; the abscess was small and E. coli viable counts were low (3.3 log,, cfulml). When an E. coli-infected clot was coinoculated i.p. with a sterile fibrin clot, single abscesses were present in three out of four animals. These were small (0.16 SD 0.09 g) and contained low numbers of E. coli (2.2 SD 2.0 log,, cfulml). (25) 616 ( These data suggest that the increased E. coli counts in abscesses initiated by double clot insertion were more likely to be due to bacterial interaction than the presence of a second intra-abdominal clot. In contrast, simultaneous intravenous or subcutaneous inoculation of B. fragilis did not act synergically with E. coli-containing clots given i.p. Abscesses were uniformly small and never contained B. fragilis.
Discussion
The importance of synergic bacterial interactions in determining the pathogencity of mixed infections has been demonstrated clearly in several model systems. Several mechanisms have been proposed to account for this relationship (Mackowiak, 1978) . One bacterial species may promote the survival of its bacterial partner in a mixed infection by providing growth factors, impairing host defence mechanisms, optimising the local micro-environment, or by transferring virulence factors. Correlation between these proposed mechanisms and the in-vivo setting has received relatively little attention, particularly in relation to intra-abdominal infections. Reznikov et al. (198 1) demonstrated that co-injection of B. fragilis with E. coli into the peritoneal cavity had no effect on the clearance of E. coli. These authors concluded that impaired phagocytosis of E. coli due to the presence of B. fragilis, a well defined in-vitro mechanism, was unlikely to be active in vivo. Studies by Dunn et al.
(1 985) demonstrated that non-viable B. fragdis were able to impair clearance of non-viable E. coli from the peritoneal cavity. However, non-viable E. coli were able to mimic the effect of B. fragilis, thereby implying that impaired clearance was a nonspecific effect mediated by large numbers of particles rather than a demonstration of E. coli-B. fragilis synergy. The inability to demonstrate synergy in these two studies may have been due to the rapid clearance of bacteria from the peritoneal cavity via the diaphragmatic lymphatics (Dunn et al., 1987) , thereby not allowing the intimate interaction required for microbial synergy. Adjuvant materials such as sterile faeces and barium (Onderdonk et al., 1976) , fibrin (Wells et al., 1985; Rotstein and Kao, 1988) , and cellulose fibres (Hagen et al., 1983) which retard bacterial clearance, are generally required to demonstrate bacterial synergy in the peritoneal cavity.
Onderdonk et al.
(1 976) demonstrated synergy between E. coli and B. fragilis with respect to abscess formation using a model in which the bacterial inoculum was mixed with barium sulphate and sterilised rat faeces. These studies also showed that mortality in mixed infections correlated with the dose of E. coli in the inoculum. Subsequent 0. D. ROTSTEIN, J. KAO AND K. HOUSTON studies with the fibrin clot peritonitis model confirmed these findings and, furthermore, demonstrated that B. fragilis could modulate the mortality rate (Rotstein et al., 1985) . The ability of Bacteroides spp. to do so did not correlate with capsulation (Rotstein et al., 1987) . The inoculum size and the particular strain of E. coli in the infecting inoculum may also determine whether B. fragilis is able to modulate E. coli-fibrin clot lethality (Wells et al., 1985; Rotstein and Kao, 1988) .
In the present studies, we used the fibrin clot model of intra-abdominal infection to examine the synergic interactions between E. coli and B. fragilis with respect to abscess formation in vivo. This model closely mimics the clinical scenario in which an infected fibrinopurulent exudate represents an important precursor to abscess formation. In this model, the addition of B. fragilis to E. coli in the infecting inoculum approximately doubled the weight of the 7-day abscess and increased the residual number of E. coli by 2-4 log,,. In a reciprocal fashion, E. coli enhanced the persistence of B.fragilis. This was particularly evident with the lower B. fragilis inocula which alone resulted in a low rate of abscess formation with small abscesses and low bacterial numbers. The addition of E. coli to these inocula resulted in consistent formation of abscesses containing high numbers of B. fragilis. With higher inocula of B. fragilis, the degree of purulence and the weight of the abscesses was again increased by the addition of E. coli. However, final B. fragilis numbers remained the same, probably because of limitation of bacterial growth within an abscess rather than a failure to demonstrate synerg . lo3 cfu) to E. coli in the fibrin clot resulted in abscesses no larger and containing no more E. coli than monomicrobial E. coli inocula. This threshold level of B. fragilis for synergic abscess formation ( > 2 x lo3 cfu) was several log,, values lower than that reported for synergic lethality with E. coli in this model (> 3 x lo7 cfu; Rotstein et al., 1987). The explanation for this difference probably lies in the different endpoints studied. Synergic lethality was characterised by an increase in mortality within the first 24-48 h. Thus, high B. fragilis inocula were required to facilitate the increased E. coli bacteraemia and subsequent increased mortality. In contrast, the prolonged interaction resulting in synergic abscess formation may have permitted lower initial inocula of B. fragilis to act synergically.
Several mechanisms have been invoked as being important in the pathogenesis of aerobic-anaerobic bacterial synergy (Mackowiak, 1978) . One mechanism, the ability of Bacteroides spp. to impair the The addition of B. fragilis at low inocula (10 Yphagocytic killing of aerobes by neutrophils, has received particular attention. Viable Bacteroides spp. are able to affect this phenomenon, whereas dead Bacteroides particles vary in their ability to do so. This depends on the method used to kill the bacteria. Boiling or killing with metronidazole removes the ability of Bacteroides spp. to impair phagocytic killing, but autoclaving at 115°C for 20 min has no effect (Ingham et al., 1981; Jones and Gemmell, 1982) . To examine the requirements for live bacteria in the production of bacterial synergy in vivo, washed heat-killed E. coli or B. fragilis particles were substituted for live bacteria in mixed inocula with their live co-pathogens. Neither was able to reproduce the synergic effect of its viable counterpart. Since one might argue that 2 x lo9 dead B. fragilis was an inappropriate substitute for 2 x lo9 live B. fragilis because of the potential growth in vivo of the latter, we also studied the combination of 2 x 10" dead B. fragilis with live E. coli and were unable to demonstrate synergy. These findings are in agreement with those of Hite et al. (1949) in which heat killing of either 'Bacteroides', now Fusobacterium, necrophorum or Streptococcus liquefaciens before their combined inoculation at a subcutaneous site prevented bacterial synergy. The failure of B. fragilis heat-killed by boiling at 100°C for 10 min to act synergically with E. coli in vivo corresponds well with in-vitro studies demonstrating that B. fragilis cells killed by boiling lost their ability to impair the phagocytic killing of E. coli by neutrophils (Ingham et al., 1981) . Further studies with B. fragilis killed by other methods are required to verify this correlation between the in-vivo and in-vitro setting. A number of studies have demonstrated that soluble factors in Bacteroides culture supernates may impair host defence mechanisms (Van Dyke et al., 1982; Namavar et al., 1983; Rotstein et al., 1986) but in the present study B. fragilis culture filtrates were unable to produce E. coli-B. fragilis synergy. This does not rule out the possibility that these factors diffused out of the fibrin mesh and were, therefore, unable to exert their synergic effect with E. coli in the fibrin clot. Conceivably, live B. fragilis mixed with E. coli might provide a local milieu in which these soluble factors are present in high concentrations for prolonged periods and are able to exert their effects.
A synergic relationship between E. coli and B. fragilis was evident when B. fragilis was inoculated within the peritoneal cavity together with an E. coli-infected clot, but not when B. fragilis was inoculated intravenously or subcutaneously. These results argue against inhibition of systemic host defences by B. fragilis as a mechanism for synergy as suggested by Rodloff et al. (1986) . The consistent presence of both bacterial species within the abscesses when both were inoculated i.p. suggests the requirement for intimate local interaction between bacteria in the production of synergy. Interestingly, in the single animal which had a small abscess following i.p. inoculation with separate clots containing E. coli and B. fragilis, the abscess was monomicrobial, containing small numbers of E. coli. While it is unclear why cross-seeding of clots with bacteria resulting in synergy did not occur in this animal, the results further demonstrate the requirement of local interaction between bacteria in the production of synergy.
